CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01653210
NCT01653210N/ACompleted
CompareCT.gov

Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes

University of Virginia·observational·Posted Jul 30, 2012·Updated Apr 8, 2020

In Brief

An observational study for Type 1 Diabetes Mellitus. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This overall research goal will be to develop a mobile-based module to improve glycemic control during the menstrual cycle in women with Type 1 diabetes mellitus (T1DM). This module will run on an Android Operating System (OS) and will be available as: (i) a stand-alone application and (ii) an important additional component to a larger system, the Diabetes Assistant (DiAs) - a mobile-based medical platform for diabetes applications. This proposal aims to build one such application or module targeting the improvement of diabetes control in younger women who experience glucose variation related to their menstrual cycle.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
CollaboratorsLifeScan

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2012
Enrollment StartAug 1, 2012
Primary CompletionJun 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.9 years ago